Source: Contract Pharma

NeuroCog Trials: NeuroCog Trials Adds to Leadership Team

With over 25 years experience, Dr. Kathleen Anne Welsh-Bohmer joins as vice president of Neurodegenerative Disorders

Read full article »
NeuroCog Trials's Competitors | NeuroCog Trials's News | NeuroCog Trials's Financials
Stay up-to-date with the latest news on NeuroCog Trials
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Richard Keefe's photo - Co-Founder & CEO of NeuroCog Trials

Co-Founder & CEO

Richard Keefe

CEO Approval Rating

46/100

Read more
Stay up-to-date with the latest news on NeuroCog Trials